Table 5.
SGRQ total and items scores between inteventional and control groups
SGRQ scores | Visiting Times | |||||
---|---|---|---|---|---|---|
| ||||||
Baseline | 4th Week | 8th Week | Diff. between of baseline to 4th | Diff. between of baseline to 4th | ||
Symptom score (%) | A | 71.20±18.71 | 52.11±22.34 | 46.78±18.10 | −19.09±12.28 | −24.33±9.76 |
B | 76.19±18.78 | 67.46±18.70 | 60.18±19.81 | −8.73±6.45 | −16.01±13.05 | |
p-value | 0.182 | 0.002 | 0.003 | 0.001 | 0.002 | |
Activity score (%) | A | 58.92±26.39 | 38.93±20.62 | 36.25±19.04 | −19.99±12.53 | −22.67±13.43 |
B | 66.89±24.49 | 56.19±24.72 | 53.21±25.25 | −10.70±9.93 | −13.68±12.15 | |
p-value | 0.235 | 0.003 | 0.003 | 0.001 | 0.002 | |
Impact score (%) | A | 45.93±2085 | 29.69±18.85 | 27.07±17.78 | −16.24±11.93 | −18.85±12.05 |
B | 48.89±20.94 | 40.14±19.97 | 39.49±21.21 | −8.75±10.33 | −9.40±13.32 | |
p-value | 0.470 | 0.007 | 0.002 | 0.001 | 0.001 | |
SGRQ score (%) | A | 50.06±19.99 | 36.21±17.93 | 33.14±16.45 | −17.85±9.10 | 20.92±9.47 |
B | 58.88±19.02 | 49.54±18.60 | 47.08±19.77 | −9.34±8.04 | −11.79±11.00 | |
p-value | 0.209 | 0.001 | 0.001 | 0.001 | 0.001 |
p-value was tested with * Mann-Whitney U Test